The surface protein internalin A (InlA) contributes to the invasion of human intestinal epithelial cells by Listeria monocytogenes. Screening of L. monocytogenes strains isolated from human clinical cases (n � 46), foods (n � 118), and healthy animals (n � 58) in the United States revealed mutations in inlA leading to premature stop codons (PMSCs) in L. monocytogenes ribotypes DUP-1052A and DUP-16635A (PMSC mutation type 1), DUP-1025A and DUP-1031A (PMSC mutation type 2), and DUP-1046B and DUP-1062A (PMSC mutation type 3). While all DUP-1046B, DUP-1062A, DUP-16635A, and DUP-1031A isolates (n � 76) contained inlA PMSCs, ribotypes DUP-1052A and DUP-1025A (n � 72) contained isolates with and without inlA PMSCs. Western immunoblotting showed that all three inlA PMSCs result in the production of truncated and secreted InlA. Searches of the Pathogen Tracker database, which contains subtype and source information for more than 5,000 L. monocytogenes isolates, revealed that the six ribotypes shown to contain isolates with inlA PMSCs were overall more commonly isolated from foods than from human listeriosis cases. L. monocytogenes strains carrying inlA PMSCs also showed significantly (P � 0.0004) reduced invasion of Caco-2 cells compared to isolates with homologous 3� inlA sequences without PMSCs. Invasion assays with an isogenic PMSC mutant further supported the observation that inlA PMSCs lead to reduced invasion of Caco-2 cells. Our data show that specific L. monocytogenes subtypes which are common among U.S. food isolates but rare among human listeriosis isolates carry inlA mutations that are associated with, and possibly at least partially responsible for, an attenuated invasion phenotype.
isolates from human listeriosis infections that were not previously characterized and 24 food isolates selected from the 58 DUP-1052A food isolates described by Gray et al. (6) to represent a variety of different ready-to-eat foods Eight ribotype DUP-1025A isolates, representing all four DUP-1025A isolates from human listeriosis infections that were not previously characterized and selected food isolates (n � 4)
All DUP-16635A isolates from foods (n � 4) that were not previously characterized
Isolates were screened by sequencing an �1,600-bp 3� fragment of inlA to identify premature stop codon mutations associated with food isolates Isolates were screened by sequencing an �1,600-bp 3� fragment of inlA to identify premature stop codon mutations associated with isolates from healthy cattle
Isolates were screened by PCR-RFLP to identify the presence of premature stop codon mutation type 3; all DUP-1062A isolates characterized by serotyping (n � 11) were serotype 1/2a
Isolates were screened by sequencing an �800-bp 3� fragment of inlA to identify the presence of premature stop codon mutation type 1; all DUP-1052A isolates characterized by serotyping (n � 10) were serotype 1/2b
Isolates were screened by sequencing an �800-bp 3� fragment of inlA to identify the presence of premature stop codon mutation type 2; all DUP-1025A isolates characterized by serotyping (n � 9) were serotype 1/2b Isolates were screened by sequencing an �800-bp 3� fragment of inlA to identify the presence of premature stop codon mutation type 1; all DUP-16635A isolates (n � 5) were serotype 1/2b
a The number of isolates characterized by serotyping included 8 DUP-1052A, 2 DUP-1025A, 1 DUP-1031A, 3 DUP-1062A, and 2 DUP-1046B isolates serotyped by Nightingale et al. (24) as well as 24 isolates that were not previously reported.
mal, and food-source populations in the United States, and (iii) determine the invasion phenotypes of L. monocytogenes strains with and without inlA PMSCs.
MATERIALS AND METHODS
Bacterial strains. Six L. monocytogenes isolate sets (Table 1) were assembled from our culture collection of �5,000 L. monocytogenes isolates to screen for the presence of inlA PMSCs among L. monocytogenes strains isolated from different source populations in the United States. All isolates included in these six sets are described in detail in Supplemental Table 1 (http://www.foodscience.cornell.edu /wiedmann/Nightingale%20Supplementary2.txt). inlA sequencing data for these isolates have not been reported previously.
inlA sequencing. L. monocytogenes isolates representing molecular subtypes commonly isolated from foods and fecal samples from healthy ruminants (isolate sets 1 and 2; Table 1 ) were screened for the presence of PMSCs in inlA by first sequencing the 3� end of inlA (approximately 800 bp) and subsequently sequenc ing an additional, approximately 800-bp fragment (5� of the initial 3� 800-bp region sequenced) if no PMSC mutations were detected in the initial 3� frag ment. To specifically screen for the presence of PMSC mutation types 1 and 2, which were previously mapped to the 3� end of inlA (24) , DNA sequencing of the 3� fragment of inlA (approximately 800 bp) was conducted. Primer sequences used for PCR amplification and/or DNA sequencing as well as PCR conditions are detailed in Supplemental Tables 2 and 3 (http://www.foodscience.cornell.edu /wiedmann/Nightingale%20Supplementary2.txt). PCR was performed using Taq polymerase (Promega, Madison, WI) as described previously (24) . PCR products were also purified, quantified, and sequenced using forward and reverse PCR primers as described previously (24) . Nucleotide sequences were proofread and aligned with Seqman and MegAlign (Lasergene software suite; DNAStar, Madison, WI), respectively.
PCR-RFLP. Partial inlA DNA sequence data for four DUP-1062A and all available DUP-1046B L. monocytogenes isolates from food samples previously uncovered the presence of a specific PMSC mutation (PMSC mutation type 3) in these isolates (24) . A PCR-restriction fragment length polymorphism (PCR RFLP) assay was developed to screen for the presence of this inlA PMSC mutation in DUP-1062A isolates from human clinical cases and from foods (Table 1 ). An analysis of inlA sequences with and without inlA PMSC mutation type 3 identified RsaI as a restriction enzyme that differentiates sequences with and without this mutation. PCR primers (Supplemental Table 2 ) were designed to amplify a 180-bp fragment of inlA encompassing PMSC mutation type 3. RsaI recognizes a sequence found in inlA sequences without PMSC mutation type 3, so L. monocytogenes isolates with PMSC mutation type 3 were expected to show a single 180-bp fragment after PCR-RFLP, while isolates without this mutation were expected to yield two fragments (117 and 63 bp). PCR was performed as described in Supplemental Table 3 . PCR products were digested with RsaI (New England Biolabs, Beverly, MA) for 1 h at 37°C and subsequently analyzed by 3.0% agarose gel electrophoresis. Isolates confirmed by DNA sequencing to carry or not carry PMSC mutation type 3 were used as positive controls.
Caco-2 invasion assays. Caco-2 invasion assays were performed essentially as previously described (28) . Briefly, L. monocytogenes isolates were grown over night at 30°C without shaking. Confluent Caco-2 monolayers were inoculated with 2 � 10 7 L. monocytogenes cells/well. Serial dilutions of the inoculum were plated on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, MI) plates. Inoculated Caco-2 monolayers were incubated for 30 min at 37°C, fol lowed by three washes with phosphate-buffered saline and the addition of fresh medium without antibiotics. Medium containing 150 �g/ml gentamicin was added at 45 min postinoculation to kill extracellular bacteria. At 90 min post inoculation, Caco-2 monolayers were washed three times with phosphate-buff ered saline. Caco-2 cells were lysed by the addition of cold sterile distilled water and vigorous pipetting. Intracellular L. monocytogenes cells were enumerated by spread plating lysed Caco-2 cell suspensions on BHI agar plates. The invasion efficiency was reported as the percentage of the inoculum recovered by the enumeration of intracellular bacteria. A standard laboratory control strain (10403S) and uninoculated BHI broth were included as controls in each invasion assay. Three independent invasion assays were performed for each L. monocy togenes strain tested ( Table 2) .
Generation of an isogenic inlA PMSC mutant. An isogenic mutant of labora tory strain 10403S (2) carrying inlA PMSC mutation type 3 (located at codon 700 of the inlA open reading frame) was generated. Site-directed mutagenesis was performed using SOE-PCR (splicing by overlap extension PCR) (10) 3 (TAG) at codon 700. The PCR products were purified and combined in a Cell wall and supernatant fractions were prepared as previously described (36) . second PCR with primers Marq 147 and 150. The 1,098-bp product was digested Equivalent amounts of culture (in optical density [OD] units) were loaded per with PstI and KpnI and ligated into pKSV7. The mutated inlA allele was verified lane. Proteins were detected by Western immunoblotting using a mouse antiby sequencing and recombined into the chromosome of L. monocytogenes 10403S
InlA antiserum provided by T. Potter (National Jewish Medical and Research by allelic exchange as previously described (3).
Center, Denver, CO) (15, 36) .
Western blotting. Western immunoblot analysis of bacterial cell wall and
Phylogenetic inference. A multiple sequence alignment of the 3� end of inlA supernatant fractions for the presence of InlA was performed on L. monocyto-(706 nucleotides) was created in MegAlign using the inlA sequences for all genes grown in LB supplemented with 50 mM morpholinepropanesulfonic acid L. monocytogenes isolates (n � 160) sequenced for this study and sequences (MOPS) adjusted to pH 7.3, 25 mM glucose-1-phosphate, and 0.2% activated containing PMSCs from our previous study (24) . This alignment was used to charcoal. Chloramphenicol was added (10 �g/ml) 10 min prior to the harvest. 
12 (12) 55 (55) 67 (67) 100.0 DUP-1046B
a Data represent 54 isolates from isolate set 4 (Table 1) , one food isolate with ribotype DUP-1052A from isolate set 1, and five human and two food isolates from the work of Nightingale et al. (24) .
b Data represent four isolates from isolate set 6 (Table 1 ) and one food isolate with ribotype DUP-16635A from isolate set 1.
c Data represent eight isolates from isolate set 5 (Table 1) , one food isolate with ribotype DUP-1025A from isolate set 1, and one human and one food isolate from the work of Nightingale et al. (24) .
d Data represent one food isolate with ribotype DUP-1031A from isolate set 1 (Table 1) .
e Data represent 62 isolates from isolate set 3 (Table 1) , one food isolate with ribotype DUP-1062A from isolate set 1, and four food isolates from the work of Nightingale et al. (24) .
f Data represent one food isolate with ribotype DUP-1046B from isolate set 1 and two food isolates from the work of Nightingale et al. (24) .
isolate for each inlA allele (n � 38), using DnaSP, version 3.99 (32) . A maximum likelihood phylogenetic tree was inferred using DNA substitution parameters selected by MODELTEST (30) and PAUP* (37), as previously described (24) .
Serotyping. Serotyping of L. monocytogenes was performed using the glass agglutination method (7, 38) and commercial Listeria antiserum (Seiken Listeria antiserum; Denka Seiken, Tokyo, Japan). Results were interpreted according to the serotyping scheme of Seeliger and Hohne (35) .
Statistical analysis. Chi-square tests were performed to describe the preva lence of PMSCs in food and human clinical isolates and to describe the distri bution of ribotypes that carry inlA PMSCs among isolates from foods and human clinical listeriosis cases. Fisher's exact test was used if expected values were below 5 for one or more cells. A nonparametric equivalent to the t test (Wilcoxon rank sum test) was used to assess the difference in invasion efficiencies between the two groups of L. monocytogenes strains studied (i.e., strains with and without premature inlA stop codons). P values of �0.05 were considered statistically significant.
Nucleotide sequence accession numbers. A single sequence representing each unique inlA allele (n � 38) identified in this study was deposited in GenBank (accession no. DQ125375 to DQ125412). Accession no. DQ125408, DQ125406, and DQ125387 represent inlA sequences containing PMSC mutation types 1, 2, and 3, respectively. Sequences for all isolates characterized by partial inlA se quencing in this study (n � 160) are available through Pathogen Tracker (www .pathogentracker.net).
RESULTS AND DISCUSSION
While previous studies described inlA PMSCs among L. monocytogenes strains isolated in France from human fecal carriers and foods as well as, less commonly, from human clinical cases (11, 13, 29, 31), we were not aware of any data on the presence and distribution of inlA PMSCs in L. monocyto genes isolates from countries other than France. Our data reported here show that (i) multiple distinct inlA PMSC mu tations are found in different L. monocytogenes EcoRI ribo types, which overall are commonly isolated from foods and rarely cause human disease in the United States; (ii) isolates carrying inlA mutations resulting in PMSCs show attenuated invasiveness in human intestinal epithelial cells; and (iii) inlA PMSC mutations 3� of the highly conserved leucine-rich repeat (LRR) region of InlA are rare among fecal isolates from healthy ruminants. Together with previous studies (11, 13, 29, 31) , our results suggest that L. monocytogenes isolates with PMSCs in inlA are distributed worldwide and may represent a significant virulence-attenuated subpopulation of L. monocy togenes commonly isolated from foods. While the occurrence of multiple distinct ecologically successful inlA PMSC muta tions suggests positive selection for the loss of cell wall-an chored InlA, the reservoir(s) of L. monocytogenes strains with secreted InlA and the selective advantages associated with these mutations remain to be established.
Multiple distinct inlA PMSCs are found in different L. mono cytogenes EcoRI ribotypes that are commonly isolated from foods and rarely cause human disease in the United States. A previous study by our group (24) identified three unique inlA PMSC mutations in four L. monocytogenes ribotypes (ribotypes DUP 1052A, DUP-1062A, DUP-1046B, and DUP-1031A). Ribo types DUP-1062A and DUP-1052A were not only previously shown to be the two most common L. monocytogenes ribotypes among more than 30,000 food samples collected in the United States (together representing 41.7% of 502 L. monocytogenes food isolates [6] ) but were also found to be significantly more common among food isolates than among human clinical iso lates (6) . We thus hypothesized that inlA PMSCs might be associated with reduced human virulence among certain L. monocytogenes subtypes found in the United States. Since previous studies in France have also found multiple mutations leading to PMSCs in the 3� region of inlA (11, 13, 29, 31) , we initially sequenced the 3� region of inlA (covering the region where PMSCs were previously identified [11, 13, 24, 29, 31] ) in 36 L. monocytogenes isolates (isolate set 1; Table 1 ) represent ing all 36 ribotypes found among 502 previously collected U.S. food isolates (6) . This isolate set included ribotypes commonly linked to human listeriosis cases (e.g., DUP-1038B, DUP 1042B, and DUP-1044A [6] ). We identified two additional ribotypes, DUP-1025A and DUP-16635A, which carry inlA PMSCs. The inlA mutations identified here occurred in the 3 . Phylogenetic tree depicting evolutionary relatedness of inlA alleles sequenced. The tree was constructed using a 706-bp 3� fragment of inlA. Alleles representing premature stop codon mutation types 1, 2, and 3 are marked PMSC 1, 2, and 3, respectively. Genetic lineage I (as determined by EcoRI ribotyping) isolates are shown in red, lineage II isolates are shown in green, and lineage III isolates are shown in blue. inlA sequence data for lineage III isolates (n � 3), which have previously been shown to be distantly related to lineage I and II isolates (42) , were used as an outgroup to root the inlA maximum likelihood tree. Bootstrap confidence measures above 50.0% for nodes in the inlA phylogram are shown at the nodes they describe. The inlA sequences used to construct this tree are available from GenBank (accession no. DQ125375 to DQ125412). same locations previously identified by our group (24) (Fig. 1) . inlA PMSCs among the isolates screened thus represent three distinct mutation types (PMSC mutation types 1 through 3), with each occurring in two ribotypes (Table 3 ). All three inlA PMSC mutations observed here appear to be distinct from those reported in previous studies that provided DNA se quence data allowing us to map the specific mutations leading to PMSCs (13, 29, 31) (Fig. 1) . We could not establish whether the mutations observed here were also distinct from those leading to truncated InlA in food and human clinical isolates collected in France (11), since these isolates were only char acterized by Western blot analysis, which does not permit a definitive identification of specific mutations leading to PMSCs. All three inlA PMSCs observed here were located within 100 aa of each other and were positioned 3� of the conserved LRR region and 5� of the C-terminal LPXTG membrane-anchoring motif (Fig. 1) . The occurrence of inlA PMSCs in this region was previously linked to the production of a truncated InlA protein that is secreted rather than anchored to the cell wall (11, 13) . Western blot analysis confirmed that the inlA PMSCs reported here also result in the production of a truncated and secreted InlA protein (Fig. 2) .
Phylogenetic analyses showed that the inlA PMSCs reported here represent three distinct evolutionary events (Fig. 3) . The clustering of the inlA sequences containing mutations leading to PMSCs is also consistent with the lineage classification of the isolates carrying these mutations (Fig. 3) . Specifically, inlA alleles carrying PMSC mutation types 1 and 2 group with other lineage I inlA sequences, and the PMSC mutation type 3 allele groups with lineage II isolates (Fig. 3) . The lineage classifica tion was also consistent with serotype classification (Table 3) . Isolates with PMSC mutation types 1 and 2 were serotype 1/2b, which is typical for lineage I strains (23) , while isolates with PMSC mutation type 3 were serotype 1/2a, which is typical for lineage II strains (23) . In a previous study (24) , sequencing the 3� 800 bp of inlA failed to reveal any PMSC mutations among 36 lineage I L. monocytogenes isolates representing serotype 4b, a serotype associated with the majority of human listeriosis .g., humans) .
d The majority of human isolates (�90%) were from invasive listeriosis cases in North America. e Animal isolates included isolates from animals with invasive listeriosis as well as fecal isolates from animals without symptoms of listeriosis, the majority of which (�95%) were from North America.
f The majority of food isolates (�95%) were from North America. *, statistically significantly (P � 0.0001) more common among food isolates than among human isolates.
g Other isolates included isolates from various environments, including food processing plants, as well as isolates of unknown origin.
cases (18) . The majority (n � 40) of the ruminant fecal isolates characterized in this study belonged to lineage II, which pre dominantly includes serotypes 1/2a and 1/2c (23) . Thus, the lack of inlA premature stop codon mutations among animal isolates does not appear to represent an overrepresentation of isolates of serotype 4b, which is predominantly found among lineage I isolates and not found in lineage II isolates. We also recently identified a frameshift mutation in the 5� portion of inlA, leading to a PMSC in the signal sequence of InlA (Fig. 1 ). This frameshift mutation was observed in L. monocytogenes isolates from foods that were characterized as ribotype DUP 1039C and serotype 1/2c (R. Orsi and M. Wiedmann, unpub lished data). Interestingly, previous studies in France only identified inlA PMSC mutations 3� of the LRR region of InlA in serotype 1/2c and 1/2a isolates (11), further confirming that the inlA PMSCs observed here represent genetic events inde pendent from those leading to the emergence of the inlA PMSCs in France. The fact that at least nine independent evolutionary events ( Fig. 1) in both of the major L. monocy togenes genetic lineages led to the generation of ecologically successful inlA alleles carrying PMSC mutations suggests the occurrence of positive selection and thus a distinct ecological advantage for a loss of cell wall-anchored InlA.
To further understand the prevalence and distribution of PMSC mutation types 1 through 3 among L. monocytogenes isolates in the United States, we assembled additional larger isolate sets (sets 3 through 6; Table 1 ) of human clinical iso lates and food isolates representing four of the six ribotypes found here to carry inlA PMSC mutations (all isolates repre senting ribotypes DUP-1031A and DUP-1046B were charac terized previously [24] ). We screened these isolates using inlA sequencing or a newly developed RsaI PCR-RFLP assay tar geting the single nucleotide polymorphism (SNP) responsible for PMSC mutation type 3, the most common mutation leading to truncated and secreted InlA. All isolates representing ribo types DUP-16635A, DUP-1031A, DUP-1046B, and DUP 1062A carried the expected inlA PMSCs (Table 3 ). In contrast, ribotypes DUP-1025A and DUP-1052A contained isolates with and without inlA PMSCs (Table 3) . While PMSC muta tions were more common among food isolates than among human clinical isolates belonging to both ribotypes DUP 1025A and DUP-1052A, this association was only statistically significant (P � 0.05) for DUP-1052A isolates (Table 3) . Ribo types DUP-1025A and DUP-1052A contained isolates with partial inlA sequences that showed 100% sequence identity (within each ribotype), with the exception of their respective PMSC mutations, suggesting a recent emergence of these inlA allelic types.
Two recent studies (6, 24) provided initial evidence that L. monocytogenes strains known to carry inlA PMSCs rarely cause human listeriosis in the United States. We conducted queries of the PathogenTracker database (www.pathogentracker.net), which contains information for �5,000 L. monocytogenes strains isolated predominantly in the United States and North America from various sources (e.g., human and animal clinical listeriosis cases, foods, healthy animals, and different environ ments), to probe the distribution of the ribotypes carrying inlA PMSCs on a larger scale. All L. monocytogenes ribotypes found here to carry inlA PMSCs were extremely rarely or never detected among animal isolates ( Table 4 ), suggesting that a full-length InlA protein may play a critical role in animal listeriosis. L. monocyto genes ribotypes (DUP-1062A, DUP-16635A, DUP-1031A, and DUP-1046B) exclusively associated with PMSC mutations and one ribotype that was not exclusively associated with a PMSC (DUP-1052A) were more commonly isolated from foods than from human clinical cases (Table 4) . A � 2 test of independence showed that ribotype DUP-1062A was significantly more com mon (P � 0.0001) among food isolates (n � 1,562) than among human clinical isolates (n � 1,009). While a total of 52 human clinical isolates grouped into one of the ribotypes found to be associated with PMSCs, only 19 of these isolates actually car ried the inlA PMSC mutations associated with the respective ribotypes, as determined by sequencing of the 3� end of inlA. Most of the human isolates carrying inlA PMSCs were ob tained from blood (n � 16), while a single isolate each was obtained from pleural fluid and a skin graft site; no isolation site data were available for one isolate. This distribution of human isolates with inlA PMSC mutations is consistent with results from a recent study in France, which showed that none of 61 L. monocytogenes isolates from abortion cases carried a truncated InlA protein (11) . While these data suggest that InlA may be critical for the ability of L. monocytogenes to cause abortions, consistent with a study that found a role for inlA in the invasion of trophoblasts (16), a recent study using a guinea pig model did not support an important role for InlA in cross ing the placenta in vivo (1) . We thus conclude that L. mono cytogenes isolates with PMSCs in inlA represent a considerable subpopulation of L. monocytogenes isolates found in food which rarely cause human disease and may have a reduced ability to cause fetal infections. Further studies using L. mono cytogenes isolates with inlA PMSCs will be necessary to evalu ate the potential of these strains to cause abortions.
L. monocytogenes isolates with PMSCs show reduced inva sion efficiencies. InlA has been shown to be sufficient for the invasion of human intestinal epithelial cells by L. monocyto genes (21) , and previous studies of L. monocytogenes isolates from France carrying inlA PMSCs showed that these isolates displayed reduced invasion with the Caco-2 human intestinal epithelial cell line (27, 28) . We paired L. monocytogenes iso lates representing each unique inlA PMSC mutation identified here with isolates with homologous partial inlA sequences (ex cept for each nonsense mutation) to assess the ability of these strains to invade Caco-2 cells (Table 2) . While all DUP-1062A isolates were shown to harbor an inlA PMSC mutation, partial inlA sequences for DUP-1062A isolates were homologous to the partial L. monocytogenes EGD-e inlA sequence (5), with the exception of PMSC mutation type 3. We thus included EGD-e, which groups into lineage II, as do all DUP-1062A iso lates, as an initial nonisogenic control for ribotype DUP-1062A. L. monocytogenes strains harboring inlA PMSCs showed signifi cantly (P � 0.0004) reduced invasion efficiencies in Caco-2 cells compared to strains with full-length InlA (Fig. 4) . Isogenic �inlA and �inlAB null mutants showed an invasion capacity similar to that of L. monocytogenes strains carrying inlA PMSCs, sup porting the critical role of a cell wall-anchored InlA protein for the invasion of human intestinal epithelial cells. The invasion efficiency of the �inlB null mutant was lower than that of the isogenic wild-type strain (10403S), but higher than that of the corresponding isogenic �inlA mutant, consistent with previous reports (14, 15) .
To further characterize the effect of inlA PMSCs on inva siveness without confounding other strain differences, we con structed an isogenic L. monocytogenes 10403S mutant (FSL W3-084; Table 2 ) with inlA PMSC mutation type 3. This iso genic mutant was shown to produce a truncated and secreted InlA protein (Fig. 2) and also showed reduced Caco-2 cell invasion efficiency, similar to natural L. monocytogenes isolates carrying PMSC types 1, 2, and 3. These data further support the observation that L. monocytogenes strains with inlA PMSCs are characterized by attenuated invasiveness and thus indicate that SNPs in inlA may be suitable targets for the development of rapid assays for the detection of virulence-attenuated L. monocytogenes. However, based on the data presented here, it is not possible to differentiate whether these inlA PMSC   FIG. 4 . Caco-2 cell invasion efficiency of L. monocytogenes isolates with inlA PMSC mutations. The isolates tested included L. monocyto genes 10403S and an isogenic mutant with inlA PMSC mutation type 3 (FSL W3-084) as well as three pairs of wild-type strains with homol ogous 3� inlA sequences, with and without the respective PMSC mu tation types 1, 2, and 3; in addition, four control strains (10403S isogenic �inlA, �inlB, and �inlA null mutants) were included ( Table  2 ). The invasion efficiency of each L. monocytogenes strain was assayed in triplicate in each independent experiment, and three independent invasion experiments were performed for each strain. Bars represent median invasion efficiencies (% of intracellular bacteria relative to initial inoculum), and error bars indicate the minimum and maximum invasion efficiencies observed for each strain or isolate. A nonpara metric approximation of a t test showed that L. monocytogenes isolates with inlA PMSC mutations have significantly (P � 0.0004) reduced invasion efficiencies in Caco-2 cells compared to isolates with an inlA gene encoding full-length InlA.
mutations are fully responsible for the attenuated virulence phenotype or whether these inlA PMSCs accumulated as a result of the evolution of environmentally adapted ecotypes with already reduced virulence, which did not require a fulllength InlA protein for ecological success. Further studies us ing a carefully planned set of isogenic mutants (including a DUP-1062A isolate with a replacement of PMSC mutation type 3) and appropriate animal infection models (17) are nec essary to more conclusively define the contribution of the inlA PMSC mutations observed here to virulence attenuation, par ticularly in light of recent data that showed that isogenic res toration of another inlA PMSC failed to completely restore virulence in a chicken embryo assay (27) .
Truncated and secreted InlA is not associated with a healthy L. monocytogenes fecal carriage state in ruminants. The occur rence of at least nine distinct evolutionary events that gave rise to ecologically successful inlA allelic variants carrying PMSC mutations supports the hypothesis that the production of a truncated and secreted InlA protein may provide a distinct selective advantage in at least some specific niche. Olier et al. (28) suggested that L. monocytogenes strains with truncated InlA may be associated with a human fecal carriage state. However, recent studies indicated that the prevalence of L. monocytogenes in human stool samples from the general pop ulation is often �1% (8, 9, 33) . Since fecal L. monocytogenes carriage in healthy farm ruminants appears to be quite com mon (20, 25, 40) , we hypothesized that a truncated and se creted InlA may be associated with L. monocytogenes fecal carriage in healthy ruminants. Screening by sequencing ap proximately 1,600 bp at the 3� end of inlA of 58 L. monocyto genes fecal isolates from healthy ruminants (set 2; Table 1 ), representing ribotypes commonly isolated from ruminant fecal samples, showed that none of these 58 isolates carried PMSCs in the 3� 1,600 bp of inlA. These results are consistent with Pathogen Tracker database query results, which showed a very low prevalence of ribotypes associated with inlA PMSCs among 1,297 animal isolates (Table 4 ). We thus conclude that ruminants, including animals with clinical listeriosis and asymptomatic fecal carriers, do not represent a reservoir for L. monocytogenes strains with inlA PMSCs.
Conclusions. While several lines of evidence suggest that L. monocytogenes strains differ in their ability to cause human disease (6, 11) , limited information on the specific genetic characteristics responsible for these virulence differences is available. In conjunction with a recent study of 150 food and 300 human isolates collected in France (11), our data strongly suggest that a considerable proportion of L. monocytogenes strains isolated from foods have a reduced ability to invade human intestinal epithelial cells. Our data also support that this attenuated invasiveness is linked to multiple distinct SNPs in inlA which lead to the production of truncated and secreted InlA molecules. Since L. monocytogenes strains with inlA PMSCs have been isolated from some human cases, further studies to determine whether human listeriosis cases caused by isolates with PMSCs in inlA are associated with specific host factors (e.g., extreme immunosuppression) are appropriate. Nevertheless, the data presented here have important impli cations for microbial risk assessments and regulations targeting L. monocytogenes by identifying genetically well-defined and biologically meaningful L. monocytogenes subpopulations that appear to have reduced human virulence. In addition to the significance of our findings for food safety and public health, our data contribute to our understanding of the ecology and evolution of L. monocytogenes. In particular, future efforts to elucidate the selective advantages associated with the produc tion of a truncated and secreted InlA protein may provide a better understanding of the function of L. monocytogenes in ternalins in different hosts and nonhost environments.
